Agfa's Open Letter to De Tijd, Mediafin and De Persgroep

Agfa HealthCareDear Sir, I noted that De Tijd, and Bert Broens in particular, is continuing without abatement its 'damage Agfa-Gevaert' campaign. In recent months, we have noticed that this journalist continuously reports on Agfa-Gevaert in a one-sided negative manner and that he doesn't hesitate to publish inaccurate information.

The most striking examples were the articles published just before the General Meeting of Shareholders held in April. In these articles, he claimed that a number of important Agfa-Gevaert shareholders would vote against certain agenda items. When we checked this with our shareholders, the information turned out to be completely false. Templeton, our main shareholder, even felt forced to issue a press release to deny the content of the articles. In this case it is clear that even the most elementary rules of objective journalism were not observed.

Another example is a series of articles with completely false information about a possible operation involving Agfa Graphics. Insiders in the business know that this campaign was inspired by the management of Punch. I leave it to you to decide if this is ethically acceptable.

More recently, the campaign is aimed at Agfa HealthCare. This business group's important successes, such as the huge contract signed with the Paris hospitals, were minimized. In today's article some details were used to create a completely negative image.

It is obvious that we are not able to win every single contract. If that would be the case, we would hold a monopoly. Furthermore, it is only normal that occasionally a colleague leaves the company. It seems to me that this shouldn't be a reason for this type of negative coverage either.

Regarding this article, not a single contact was made with our company in order to at least check the accuracy of the information or to obtain additional information.

Again, I leave it to you to judge the quality of this kind of journalism.

I personally have put all means of communication at Bert Broens' disposal, my private mobile phone number included. I believe I can't do more than that.

Agfa-Gevaert is one of the few Belgian companies with very important global market shares in almost all of its activities. This goes for both our graphic and our healthcare business. Our competitors are therefore only too anxious to translate and spread this kind of articles amongst our customers.

Why a newspaper, which is presenting itself as the newspaper for the entrepreneurs in Flanders, is leading such a damaging campaign, goes beyond my comprehension.

It will therefore come to you as no surprise that I will demand - as a right to reply - the publication of a text from my hand, of comparable length in De Tijd.

In my opinion, this is the strict minimum that can be done to somewhat limit the significant economic damage created by this campaign.

Jo Cornu
CEO Agfa-Gevaert

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and specific industrial applications (Agfa Materials). Agfa's headquarters are in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,283 million Euro in 2007.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2007 were 1,392 million Euro, accounting for 43% of total group sales. For more information on Agfa HealthCare, please visit www.agfa.com/healthcare.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

AI-Based App can Help Physicians Find Sk…

A mobile app that uses artificial intelligence, AI, to analyse images of suspected skin lesions can diagnose melanoma with very high precision. This is shown in a study led from...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...